Treatment setting and buprenorphine discontinuation: an analysis of multi-state insurance claims.

Kevin Young XuAlex K GertnerShelly F GreenfieldArthur Robin WilliamsRichard A Grucza

Published in: Addiction science & clinical practice (2024)

Buprenorphine discontinuation is high across outpatient PCP, psychiatry, and SUD treatment facility settings, with potentially lower treatment retention among Medicaid enrollees receiving care from SUD facilities and PCPs.

Keyphrases

health insurance
palliative care
chronic pain
pain management